Home
Soleus Private Equity Fund III reported a 5.2% stake in Prelude Therapeutics PRLD · 3,378,378 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.2%
- Last report
- First report
- Shares held
- 3,378,378 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/04/21
- Filed
- 26/07/08
First 5%+ report · 5.2% stake
Prelude Therapeutics trades, last 26 weeks
What else happened in Prelude Therapeutics around then
Filed or reported within 30 days of the trade day · 03/22~05/21Soleus Private Equity Fund III's other 5% stake reports
- Soleus Private Equity Fund III
5% stakeNuvectis Pharma
5% stakeNuvectis Pharma
NVCT
5.1% stake
1,648,024 sh
5.1% stake
Filed 08/06
- Soleus Private Equity Fund III
5% stakeCalciMedica
5% stakeCalciMedica
CALC
2.4% stake
391,952 sh
2.4% stake
Filed 05/08
- Soleus Private Equity Fund III
5% stakeAprea Therapeutics
5% stakeAprea Therapeutics
APRE
9.99% stake
1,271,080 sh
9.99% stake
Filed 04/01
- Soleus Private Equity Fund III
5% stakeInvivyd
5% stakeInvivyd
IVVD
2.8% stake
7,708,727 sh
2.8% stake
Filed 02/12
- Soleus Private Equity Fund III
5% stakeInvivyd
5% stakeInvivyd
IVVD
5.1% stake
10,850,000 sh
5.1% stake
Filed 25/10/14
